55 Results

People

  1. Iyer
    Iyer
  2. Rosenberg
    Rosenberg
  3. Solit
    Solit
  4. Al-Ahmadie
    Al-Ahmadie
  5. Bochner
    Bochner
  6. Cha
    Cha
  7. Petrini
    Petrini
  8. Zhao
    Zhao
  9. Abdel-Wahab
    Abdel-Wahab
  10. Berger
    Berger

Groups

  1. GSK Faculty (33)
  2. Department of Medicine (24)
  3. Sloan Kettering Institute Postdocs (20)
  4. Solid Tumor Oncology Division (17)
  5. Sloan Kettering Institute Faculty (15)
  6. Molecular Biology Program Faculty (12)
  7. Genitourinary Oncology Service (11)
  8. Human Oncology and Pathogenesis Program (11)
  9. Department of Pathology and Laboratory Medicine (10)
  10. Center for Hematologic Malignancies (8)
  1. "dna damage response"
Formats
  1. Journal Article (39)
  2. Review (10)
  3. Editorial (4)
  4. Research Letter (2)
Groups
  1. GSK Faculty (33)
  2. Department of Medicine (24)
  3. Sloan Kettering Institute Postdocs (20)
  4. Solid Tumor Oncology Division (17)
  5. Sloan Kettering Institute Faculty (15)
  6. Molecular Biology Program Faculty (12)

More Groups

People
  1. Gopakumar Iyer (10)
  2. David Solit (6)
  3. Jonathan Rosenberg (6)
  4. Hikmat Al-Ahmadie (5)
  5. Bernard Bochner (4)
  6. Dean Bajorin (4)

More People

Years
  1. 2025 (3)
  2. 2024 (10)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. JCO Precision Oncology (3)
  2. Journal of Biological Chemistry (3)
  3. Science Translational Medicine (3)
  4. Blood (2)
  5. Cancer Cell (2)
  6. Cell (2)

More Publications

Publishers
  1. Elsevier Inc. (10)
  2. Cell Press (9)
  3. American Association for the Advancement of Science (3)
  4. American Society for Biochemistry and Molecular Biology (3)
  5. American Society of Clinical Oncology (3)
  6. American Society of Hematology (3)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers
    Journal Article

    Grimsley, H. E.; Antczak, M.; Reddin, I. G.; Weiler, N.; McLaughlin, K. M.; Rothweiler, F.; Haas, J.; Nist, A.; Mernberger, M.; Stiewe, T.; more...
    Cancer Letters (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA and response to cisplatin-based chemotherapy in patients with metastatic urothelial carcinoma enrolled in CALGB 90601 (Alliance)
    Journal Article

    Guercio, B. J.; Whiting, K.; Shah, R. H.; Ballman, K. V.; Halabi, S.; Regazzi, A. M.; Milbank, J. H.; Bajorin, D. F.; Beltran, H.; Morris, M. J.; more...
    European Urology Open Science (2025)

    Fulltext@MSK | Save
  • Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/ DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
    Research Letter

    Lewis, N. E.; Petrova-Drus, K.; Sardana, R.; Huet, S.; Gao, Q.; Sethi, S.; Vanderbilt, C.; Xiao, W.; Roshal, M.; Baik, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
    Journal Article

    Wortzel, I.; Seo, Y.; Akano, I.; Shaashua, L.; Tobias, G. C.; Hebert, J.; Kim, K. A.; Kim, D.; Dror, S.; Liu, Y.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
    Journal Article

    Chakraborty, S.; Sen, U.; Ventura, K.; Jethalia, V.; Coleman, C.; Sridhar, S.; Banerjee, A.; Ozakinci, H.; Mahendravarman, Y.; Snioch, K.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • DNA damage response alterations predict for neoadjuvant chemotherapy sensitivity in muscle-invasive bladder cancer: A correlative analysis of the SWOG S1314 trial
    Journal Article

    Iyer, G.; Tangen, C. M.; Sarfaty, M.; Regazzi, A. M.; Lee, I. L.; Fong, M.; Choi, W.; Dinney, C. P. N.; Flaig, T. W.; Thompson, I. M. Jr; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers
    Journal Article

    Belli, C.; Boscolo Bielo, L.; Repetto, M.; Crimini, E.; Scalia, R.; Diana, A.; Orefice, J.; Ascione, L.; Pellizzari, G.; Fusco, N.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
    Journal Article

    Bielo, L. B.; Repetto, M.; Crimini, E.; Belli, C.; Setola, E.; Parma, G.; Fusco, N.; Barberis, M.; Rocco, E. G.; Marra, A.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • The ribotoxic stress response drives UV-mediated cell death
    Journal Article

    Sinha, N. K.; McKenney, C.; Yeow, Z. Y.; Li, J. J.; Nam, K. H.; Yaron-Barir, T. M.; Johnson, J. L.; Huntsman, E. M.; Cantley, L. C.; Ordureau, A.; more...
    Cell (2024)

    Fulltext@MSK | Save